PROK insider trading

NasdaqCM Healthcare

PROKIDNEY CORP. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
101
Last 90 days
7
Buys / sells
18% / 50%
Market cap
$694.93M

About PROKIDNEY CORP.

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Company website: prokidney.com

PROK insider activity at a glance

FilingIQ has scored 101 insider transactions for PROK since Jul 11, 2022. The most recent filing in our index is dated Apr 28, 2026.

Across the full history, 18 open-market purchases and 50 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PROK insider trades is 53.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest PROK Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for PROK?
FilingIQ tracks 101 Form 4 insider transactions for PROK (PROKIDNEY CORP.), covering filings from Jul 11, 2022 onwards. 7 of those were filed in the last 90 days.
Are PROK insiders net buyers or net sellers?
Across the full Form 4 history for PROK, 18 transactions (18%) were open-market purchases and 50 (50%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PROK insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PROK in?
PROKIDNEY CORP. (PROK) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $694.93M.

Methodology & sources

Every PROK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.